James Loerop

James Loerop

Chief Business OfficeratAclaris Therapeutics· In proxies 2023–2025

Pay in FY2023Aclaris Therapeutics stock -93.3% the same year

James Loerop was paid $2.3M in FY2023 (Dec). Aclaris Therapeutics stock fell 93.3% that year.

Pay$100 in the stock at the end of FY22 → $7
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 3 yr
    • Chief Business Officer2023 – Present · 3 yrStock in role -74%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?